MARK FREIJAT
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology SCOTTSDALE, AZ NPI 1124337621
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology AZ Amgen Inc. All categories
General Payments — all program years on this page
$7,304.35
- Category: General Payments
- Program years: PY2020–2024
- Record count: 333
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,486.17 across 117 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,387.17 | 116 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $697.09 | 32 |
| UCB, Inc. | $220.25 | 10 |
| GlaxoSmithKline, LLC. | $206.84 | 12 |
| ABBVIE INC. | $199.31 | 9 |
| PFIZER INC. | $177.92 | 10 |
| Janssen Biotech, Inc. | $136.96 | 7 |
| Mallinckrodt Hospital Products Inc. | $114.30 | 5 |
| Lilly USA, LLC | $107.73 | 5 |
| Actelion Pharmaceuticals US, Inc. | $99.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $75.09 | 4 |
| SOBI, INC | $69.35 | 3 |
| GENZYME CORPORATION | $61.01 | 3 |
| Sandoz Inc. | $56.29 | 3 |
| SCILEX PHARMACEUTICALS INC. | $53.03 | 3 |
| Acerta Pharma LLC | $51.47 | 3 |
| Aurinia Pharma U.S., Inc. | $47.00 | 2 |
| E.R. Squibb & Sons, L.L.C. | $45.77 | 2 |
| Biocon Biologics Inc | $43.09 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.67 | 1 |
By program year
Records — PY2024 (117)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.